The year in arrhythmias-2007: Part I

Heart Rhythm

Volumn 5, Issue 5, 2008, Pages 742-748

  Josephson, Mark E ^a   Rosen, Michael R ^b   Tomaselli, Gordon F ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Columbia University New York ^*  (United States)

^c Donald W Reynolds Cardiovascular Clinical Research Center   (United States)

Author keywords

Heart failure; Sudden cardiac death

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM CHANNEL L TYPE; MICRORNA; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNQ1; RANOLAZINE;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CATHETER ABLATION; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; GENE MUTATION; GENETIC ANALYSIS; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; MESENCHYMAL STEM CELL; MORTALITY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN DEATH;

ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; CARDIAC ELECTROPHYSIOLOGY; CATHETER ABLATION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; RISK ASSESSMENT;

EID: 42749088238     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.03.012     Document Type: Article

References (57)

1. Yang B., Lin H., Xiao J., et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13 (2007) 486-491
2. Chen J.F., Mandel E.M., Thomson J.M., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38 (2006) 228-233
3. Zhao Y., Samal E., and Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436 (2005) 214-220
4. Rao P.K., Kumar R.M., Farkhondeh M., et al. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A 103 (2006) 8721-8726
5. Lehtonen A., Fodstad H., Laitinen-Forsblom P., et al. Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes. Heart Rhythm 4 (2007) 603-607
6. Moss A.J., Shimizu W., Wilde A.A., et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 115 (2007) 2481-2489
7. Ohno S., Zankov D.P., Yoshida H., et al. N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT syndrome. Heart Rhythm 4 (2007) 332-340
8. Antzelevitch C., Pollevick G.D., Cordeiro J.M., et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115 (2007) 442-449
9. Bhuiyan Z.A., van den Berg M.P., van Tintelen J.P., et al. Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features. Circulation 116 (2007) 1569-1576
10. Pfahnl A.E., Viswanathan P.C., Weiss R., et al. A sodium channel pore mutation causing Brugada syndrome. Heart Rhythm 4 (2007) 46-53
11. + current and causes inherited arrhythmias. Circulation 116 (2007) 2260-2268
12. Van Norstrand D.W., Valdivia C.R., Tester D.J., et al. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 116 (2007) 2253-2259
13. Fodstad H., Swan H., Laitinen P., et al. Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland. Ann Med 36 Suppl 1 (2004) 53-63
14. Yang P., Kanki H., Drolet B., et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 105 (2002) 1943-1948
15. Paulussen A.D., Gilissen R.A., Armstrong M., et al. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J Mol Med 82 (2004) 182-188
16. Schwartz P.J. Idiopathic long QT syndrome: progress and questions. Am Heart J 109 (1985) 399-411
17. Schwartz P.J., Moss A.J., Vincent G.M., et al. Diagnostic criteria for the long QT syndrome. An update. Circulation 88 (1993) 782-784
18. Keating M., Atkinson D., Dunn C., et al. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 252 (1991) 704-706
19. Hofman N., Wilde A.A., Kaab S., et al. Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system?. Eur Heart J 28 (2007) 575-580
20. Jeyaraj D., Wilson L.D., Zhong J., et al. Mechanoelectrical feedback as novel mechanism of cardiac electrical remodeling. Circulation 115 (2007) 3145-3155
21. Wecke L., Rubulis A., Lundahl G., et al. Right ventricular pacing-induced electrophysiological remodeling in the human heart and its relationship to cardiac memory. Heart Rhythm 4 (2007) 1477-1486
22. Ruan H., Mitchell S., Vainoriene M., et al. Gi alpha 1-mediated cardiac electrophysiological remodeling and arrhythmia in hypertrophic cardiomyopathy. Circulation 116 (2007) 596-605
23. Jones S.A., Boyett M.R., and Lancaster M.K. Declining into failure: the age-dependent loss of the L-type calcium channel within the sinoatrial node. Circulation 115 (2007) 1183-1190
24. Jones S.A., Lancaster M.K., and Boyett M.R. Ageing-related changes of connexins and conduction within the sinoatrial node. J Physiol 560 (2004) 429-437
25. Tabereaux P.B., Walcott G.P., Rogers J.M., et al. Activation patterns of Purkinje fibers during long-duration ventricular fibrillation in an isolated canine heart model. Circulation 116 (2007) 1113-1119
26. Newton J.C., Smith W.M., and Ideker R.E. Estimated global transmural distribution of activation rate and conduction block during porcine and canine ventricular fibrillation. Circ Res 94 (2004) 836-842
27. Allison J.S., Qin H., Dosdall D.J., et al. The transmural activation sequence in porcine and canine left ventricle is markedly different during long-duration ventricular fibrillation. J Cardiovasc Electrophysiol 18 (2007) 1306-1312
28. Buxton A.E., Lee K.L., Hafley G.E., et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 50 (2007) 1150-1157
29. Chow T. et al. Primary results from the microvolt T wave alternans testing for risk stratification of post M1 patients (Master 1) trial. AHA Scientific Sessions 2007.
30. Salerno-Uriarte J.A., De Ferrari G.M., Klersy C., et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. J Am Coll Cardiol 50 (2007) 1896-1904
31. Kusmirek S.L., and Gold M.R. Dynamic changes of T-wave alternans: does it predict short-term arrhythmia vulnerability?. J Cardiovasc Electrophysiol 18 (2007) 518-519
32. Nearing B.D., and Verrier R.L. Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. J Appl Physiol 92 (2002) 541-549
33. Nieminen T., Lehtimaki T., Viik J., et al. T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test. Eur Heart J 28 (2007) 2332-2337
34. Exner D.V., Kavanagh K.M., Slawnych M.P., et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 50 (2007) 2275-2284
35. Huikuri H.V., Mahaux V., and Bloch-Thomsen P.E. Cardiac arrhythmias and risk stratification after myocardial infarction: results of the CARISMA pilot study. Pacing Clin Electrophysiol 26 (2003) 416-419
36. Schmidt A., Azevedo C.F., Cheng A., et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115 (2007) 2006-2014
37. Perry M., Sachse F.B., and Sanguinetti M.C. Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator. Proc Natl Acad Sci U S A 104 (2007) 13827-13832
38. Maltsev V.A., and Undrovinas A. Late sodium current in failing heart: Friend or foe?. Prog Biophys Mol Biol 96 (2008) 421-451
39. Scirica B.M., Morrow D.A., Hod H., et al. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 116 (2007) 1647-1652
40. Cho H.C., Kashiwakura Y., and Marban E. Creation of a biological pacemaker by cell fusion. Circ Res 100 (2007) 1112-1115
41. Plotnikov A.N., Shlapakova I., Szabolcs M.J., et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation 116 (2007) 706-713
42. Grimm W., Stula A., Sharkova J., et al. Outcomes of elderly recipients of implantable cardioverter defibrillators. Pacing Clin Electrophysiol 30 Suppl 1 (2007) S134-S138
43. Healey J.S., Hallstrom A.P., Kuck K.H., et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J 28 (2007) 1746-1749
44. Cuculich P.S., Sanchez J.M., Kerzner R., et al. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 30 (2007) 207-213
45. Klug D., Balde M., Pavin D., et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 116 (2007) 1349-1355
46. Kenigsberg D.N., Mirchandani S., Dover A.N., et al. Sensing failure associated with the Medtronic Sprint Fidelis defibrillator lead. J Cardiovasc Electrophysiol 19 (2008) 27-274
47. Hauser R.G., Kallinen L.M., Almquist A.K., et al. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 4 (2007) 892-896
48. Costea A., Rardon D.P., Padanilam B.J., et al. Complications associated with generator replacement in response to device advisories. J Cardiovasc Electrophysiol 19 (2008) 266-269
49. Reddy V.Y., Reynolds M.R., Neuzil P., et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357 (2007) 2657-2665
50. Marchlinski F.E. Perivalvular fibrosis and monomorphic ventricular tachycardia: toward a unifying hypothesis in nonischemic cardiomyopathy. Circulation 116 (2007) 1998-2001
51. Dalal D., Jain R., Tandri H., et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 50 (2007) 432-440
52. Yamada T., Murakami Y., Yoshida N., et al. Preferential conduction across the ventricular outflow septum in ventricular arrhythmias originating from the aortic sinus cusp. J Am Coll Cardiol 50 (2007) 884-891
53. Eckart R.E., Hruczkowski T.W., Tedrow U.B., et al. Sustained ventricular tachycardia associated with corrective valve surgery. Circulation 116 (2007) 2005-2011
54. Zeppenfeld K., Schalij M.J., Bartelings M.M., et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation 116 (2007) 2241-2252
55. Beshai J.F., Grimm R.A., Nagueh S.F., et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 357 (2007) 2461-2471
56. Winckels S.K., Thomsen M.B., Oosterhoff P., et al. High-septal pacing reduces ventricular electrical remodeling and proarrhythmia in chronic atrioventricular block dogs. J Am Coll Cardiol 50 (2007) 906-013
57. Yoshida K., Seo Y., Yamasaki H., et al. Effect of triangle ventricular pacing on haemodynamics and dyssynchrony in patients with advanced heart failure: a comparison study with conventional bi-ventricular pacing therapy. Eur Heart J 28 (2007) 2610-2619